FDAFDA · Food and drugs·Recall number D-712-2015
Hydrochlorothiazide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Published April 29, 2015 · Recall initiated: November 14, 2014
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recall details
- Manufacturer
- Attix Pharmaceuticals
- Distributor
- Nationwide to compounding pharmacies and research organizations.
- Lot
- All lots repackaged and distributed between 01/05/12 to 02/12/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Canada
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.